Latest period
$113.80M
YoY change
+32.3%
5Y CAGR
+46.6%
Peak year (2025)
$569.30M
Latest annual
$569.30M
Operating Cash Flow history chart for Insulet (PODD) from 2004 to 2025
Latest: $569.30M
Operating Cash Flow growth chart for Insulet (PODD) from 2004 to 2025
Latest: +32.3%
Operating Cash Flow history table for Insulet (PODD) from 2004 to 2025
| 2025 | $569.30M | +32.3% | +$139.00M | ||
| 2024 | $430.30M | +195.3% | +$284.60M | ||
| 2023 | $145.70M | +22.4% | +$26.70M | ||
| 2022 | $119.00M | -274.7% | +$187.10M | ||
| 2021 | −$68.10M | -181.1% | −$152.10M | ||
| 2020 | $84.00M | -14.6% | −$14.40M | ||
| 2019 | $98.40M | +174.1% | +$62.50M | ||
| 2018 | $35.90M | -13.1% | −$5.40M | ||
| 2017 | $41.30M | +159.6% | +$25.39M | ||
| 2016 | $15.91M | -226.8% | +$28.46M | ||
| 2015 | −$12.55M | -240.7% | −$21.47M | ||
| 2014 | $8.92M | +166.4% | +$5.57M | ||
| 2013 | $3.35M | -111.5% | +$32.41M | ||
| 2012 | −$29.06M | +14.2% | −$3.61M | ||
| 2011 | −$25.45M | -28.6% | +$10.17M | ||
| 2010 | −$35.63M | -27.8% | +$13.70M | ||
| 2009 | −$49.32M | -40.3% | +$33.29M | ||
| 2008 | −$82.61M | +64.0% | −$32.24M | ||
| 2007 | −$50.37M | +58.3% | −$18.55M | ||
| 2006 | −$31.82M | +56.6% | −$11.50M | ||
| 2005 | −$20.32M | +55.6% | −$7.26M | ||
| 2004 | −$13.06M | — | — |
- 2025$569.30M+32.3%
- 2024$430.30M+195.3%
- 2023$145.70M+22.4%
- 2022$119.00M-274.7%
- 2021−$68.10M-181.1%
- 2020$84.00M-14.6%
- 2019$98.40M+174.1%
- 2018$35.90M-13.1%
- 2017$41.30M+159.6%
- 2016$15.91M-226.8%
- 2015−$12.55M-240.7%
- 2014$8.92M+166.4%
- 2013$3.35M-111.5%
- 2012−$29.06M+14.2%
- 2011−$25.45M-28.6%
- 2010−$35.63M-27.8%
- 2009−$49.32M-40.3%
- 2008−$82.61M+64.0%
- 2007−$50.37M+58.3%
- 2006−$31.82M+56.6%
- 2005−$20.32M+55.6%
- 2004−$13.06M—
Operating Cash Flow values are taken from Insulet's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at Insulet (PODD)
Operating Cash Flow for Insulet (PODD): headline value $113.80M · YoY +32.3%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Insulet (PODD) most recent annual operating cash flow stands at $569.30M (2025) – surged 32.3% year-over-year.
Insulet operating cash flow has grown for 4 consecutive years, with a +46.6% compound annual growth rate over 2020–2025 (5 years).
Across the available history, operating cash flow reached its high of $569.30M in 2025 and its low of −$82.61M in 2008.
Insulet Operating Cash Flow by Year
Insulet Operating Cash Flow 2025: $569.30M
In 2025, Insulet reported operating cash flow of $569.30M, surged 32.3% from 2024. This figure represents the highest annual value in the available history.
Insulet Operating Cash Flow 2024: $430.30M
Insulet operating cash flow in 2024 was $430.30M, surged 195.3% from 2023.
Insulet Operating Cash Flow 2023: $145.70M
2023's operating cash flow for Insulet came in at $145.70M, grew 22.4% from 2022.
Insulet Operating Cash Flow 2022: $119.00M
Insulet posted operating cash flow of $119.00M in 2022, plunged 274.7% below 2021.
Insulet Operating Cash Flow 2021: −$68.10M
Insulet operating cash flow in 2021 was −$68.10M.
See more financial history for Insulet (PODD).
Sector peers by Operating Cash Flow
Healthcare peers of Insulet (PODD), ranked by their latest operating cash flow
| $24.53B | |
| $19.70B | |
| $19.03B | |
| $18.56B | |
| $16.81B | |
| $16.47B | |
| $14.57B | |
| $9.96B |
- $24.53B
- $19.70B
- $19.03B
- $18.56B
- $16.81B
- $16.47B
- $14.57B
- $9.96B
Frequently asked questions
Insulet (PODD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation